Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 155

Similar articles for PubMed (Select 23686698)

1.

Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients.

Noureddin M, Yates KP, Vaughn IA, Neuschwander-Tetri BA, Sanyal AJ, McCullough A, Merriman R, Hameed B, Doo E, Kleiner DE, Behling C, Loomba R; NASH CRN.

Hepatology. 2013 Nov;58(5):1644-54. doi: 10.1002/hep.26465. Epub 2013 Oct 2.

2.

Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease.

Hossain N, Afendy A, Stepanova M, Nader F, Srishord M, Rafiq N, Goodman Z, Younossi Z.

Clin Gastroenterol Hepatol. 2009 Nov;7(11):1224-9, 1229.e1-2. doi: 10.1016/j.cgh.2009.06.007. Epub 2009 Jun 25.

PMID:
19559819
3.

Ethnicity and nonalcoholic fatty liver disease.

Bambha K, Belt P, Abraham M, Wilson LA, Pabst M, Ferrell L, Unalp-Arida A, Bass N; Nonalcoholic Steatohepatitis Clinical Research Network Research Group.

Hepatology. 2012 Mar;55(3):769-80. doi: 10.1002/hep.24726.

4.

Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.

Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD, Goodman Z, Younossi ZM.

Obes Surg. 2005 Mar;15(3):310-5.

PMID:
15826462
5.

Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease.

Kowdley KV, Belt P, Wilson LA, Yeh MM, Neuschwander-Tetri BA, Chalasani N, Sanyal AJ, Nelson JE; NASH Clinical Research Network.

Hepatology. 2012 Jan;55(1):77-85. doi: 10.1002/hep.24706. Epub 2011 Dec 6.

6.

Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).

Verma S, Jensen D, Hart J, Mohanty SR.

Liver Int. 2013 Oct;33(9):1398-405. doi: 10.1111/liv.12226. Epub 2013 Jun 13.

PMID:
23763360
7.

Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease.

Neuschwander-Tetri BA, Clark JM, Bass NM, Van Natta ML, Unalp-Arida A, Tonascia J, Zein CO, Brunt EM, Kleiner DE, McCullough AJ, Sanyal AJ, Diehl AM, Lavine JE, Chalasani N, Kowdley KV; NASH Clinical Research Network.

Hepatology. 2010 Sep;52(3):913-24. doi: 10.1002/hep.23784.

8.

Pathologic features associated with fibrosis in nonalcoholic fatty liver disease.

Gramlich T, Kleiner DE, McCullough AJ, Matteoni CA, Boparai N, Younossi ZM.

Hum Pathol. 2004 Feb;35(2):196-9.

PMID:
14991537
9.

Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease.

Tandra S, Yeh MM, Brunt EM, Vuppalanchi R, Cummings OW, Unalp-Arida A, Wilson LA, Chalasani N; NASH Clinical Research Network (NASH CRN).

J Hepatol. 2011 Sep;55(3):654-9. doi: 10.1016/j.jhep.2010.11.021. Epub 2010 Dec 21.

10.

Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.

Liew PL, Lee WJ, Lee YC, Wang HH, Wang W, Lin YC.

Obes Surg. 2006 Dec;16(12):1584-93.

PMID:
17217634
11.

Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease.

Kistler KD, Brunt EM, Clark JM, Diehl AM, Sallis JF, Schwimmer JB; NASH CRN Research Group.

Am J Gastroenterol. 2011 Mar;106(3):460-8; quiz 469. doi: 10.1038/ajg.2010.488. Epub 2011 Jan 4.

12.

Is increased red cell distribution width an indicating marker of nonalcoholic steatohepatitis and fibrotic stage?

Cengiz M, Candır BA, Yılmaz G, Akyol G, Ozenirler S.

World J Gastroenterol. 2013 Nov 14;19(42):7412-8. doi: 10.3748/wjg.v19.i42.7412.

13.

[Clinical and histological features of non-alcoholic fatty liver disease].

Shi JP, Xun YH, Hu CB, Zhang L, Liu H, Lou GQ, Fan JG.

Zhonghua Gan Zang Bing Za Zhi. 2009 Nov;17(11):812-6. Chinese.

PMID:
19958638
14.

Gallstone disease does not predict liver histology in nonalcoholic fatty liver disease.

Yilmaz Y, Ayyildiz T, Akin H, Colak Y, Ozturk O, Senates E, Tuncer I, Dolar E.

Gut Liver. 2014 May;8(3):313-7. doi: 10.5009/gnl.2014.8.3.313.

15.

Nonalcoholic steatohepatitis (NASH) with diabetes: predictors of liver fibrosis.

Amarapurka DN, Amarapurkar AD, Patel ND, Agal S, Baigal R, Gupte P, Pramanik S.

Ann Hepatol. 2006 Jan-Mar;5(1):30-3.

PMID:
16531962
16.

Prevalence and associated metabolic factors of fatty liver disease in the elderly.

Wang Z, Xu M, Peng J, Jiang L, Hu Z, Wang H, Zhou S, Zhou R, Hultström M, Lai EY.

Exp Gerontol. 2013 Aug;48(8):705-9. doi: 10.1016/j.exger.2013.05.059. Epub 2013 May 27.

PMID:
23721951
17.

Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease.

Patton HM, Yates K, Unalp-Arida A, Behling CA, Huang TT, Rosenthal P, Sanyal AJ, Schwimmer JB, Lavine JE.

Am J Gastroenterol. 2010 Sep;105(9):2093-102. doi: 10.1038/ajg.2010.152. Epub 2010 Apr 6.

18.

Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents.

Xanthakos S, Miles L, Bucuvalas J, Daniels S, Garcia V, Inge T.

Clin Gastroenterol Hepatol. 2006 Feb;4(2):226-32.

PMID:
16469684
19.

Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease.

Charlton M, Angulo P, Chalasani N, Merriman R, Viker K, Charatcharoenwitthaya P, Sanderson S, Gawrieh S, Krishnan A, Lindor K.

Hepatology. 2008 Feb;47(2):484-92. doi: 10.1002/hep.22063.

20.

A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver.

Pais R, Charlotte F, Fedchuk L, Bedossa P, Lebray P, Poynard T, Ratziu V; LIDO Study Group.

J Hepatol. 2013 Sep;59(3):550-6. doi: 10.1016/j.jhep.2013.04.027. Epub 2013 May 9.

PMID:
23665288
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk